Molecular ESR1 changes may signal symptomatic progression before imaging in metastatic breast cancer, supporting camizestrant for improved quality of life.

Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical ...

The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...

Small cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer, with a five-year survival rate of only 5%.

A study has found that people exercise regularly, quit smoking, and practice five other health strategies can improve their ...

Datopotamab deruxtecan received FDA approval for HR+/HER2– breast cancer, improving progression-free survival and overall ...

A new study adds to the research that night-shift work can be deadly, increasing breast cancer risk and speeding it's spread, ...

Among patients with psoriasis who have active or recent cancer, biologic therapies show similar cancer progression or recurrence and serious infection rates compared with conventional systemic agents.

Disrupted sleep schedules may change breast tissue and immune function, helping aggressive breast cancer grow faster.

Oropharyngeal cancer is the most common type of throat cancer. After your diagnosis, you will learn the stage of the cancer. The stage lets you know how far, if at all, the cancer has spread from the ...